Asthma Spacers Market to Reach US$ 1,803.93 Mn by 2026
Global asthma spacers market was valued at US$ 1,330.56 Mn in 2017. It is expected to expand at a CAGR of 3.7% from 2018 to 2026. Technological advancements in spacer devices is likely to propel the market in the near future.
Global asthma spacers market was valued at US$ 1,330.56 Mn in 2017. It is expected to expand at a CAGR of 3.7% from 2018 to 2026. Technological advancements in spacer devices is likely to propel the market in the near future.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Rise in the prevalence rate of asthma is creating a significant socioeconomic impact
across the globe, which, in turn, is propelling the demand for asthma spacers.
Inhalation is the first line administration route for asthma management. Nebulizers
and metered dose inhalers are widely used for the management of asthma.
Key players profiled in this report are Koninklijke Philips N.V, Trudell Medical
International, Medical Development International, Merck & Co., Pari Gmbh,
AstraZeneca, and GlaxoSmithKline plc.
Companies operating in the global asthma spacers market focus on strategic
collaborations to develop new products in the emerging regions such as Asia
Pacific and Latin America.
©2019 Transparency Market Research, All Rights Reserved
Change language